Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026)
Pro Dex (PDEX) posted Income from Continuing Operations of 3938000.0 for Q1 2026, up 80.06% sequentially from 2187000.0 in Q4 2025, and up 20.24% YoY from 3275000.0 in Q1 2025.
Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Pro Dex has reported Income from Continuing Operations for 14 years, with the latest figure at 3938000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 20.24% year-over-year to 3938000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12002000.0 (up 28.12% YoY) and the FY2025 annual result came in at 8978000.0, up 322.1% from the prior year.
- Income from Continuing Operations climbed to 3938000.0 in Q1 2026 per PDEX's latest filing, from 2187000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 4680000.0 in Q3 2025 and troughed at 615000.0 in Q3 2023.
- A 5-year average of 1922235.29 and a median of 2040000.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations slumped 151.12% in 2023, then jumped 500.98% in 2024.
- Over 5 years, Income from Continuing Operations stood at 2752000.0 in 2022, then tumbled by 81.83% to 500000.0 in 2023, then jumped by 308.0% to 2040000.0 in 2024, then rose by 7.21% to 2187000.0 in 2025, then soared by 80.06% to 3938000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 3938000.0, 2187000.0, and 4680000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Pro Dex | 209.47 Mn | 198.49 Mn | 6.13 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 655,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | -615,000.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 574,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.10 Mn |